Skip to Main Content

Precision Oncology & Advancing Personalized Cancer Care

Cambridge Associates

Precision oncology represents an exciting shift in cancer treatment from a one-size-fits-all approach to personalized care based on each patient’s unique cancer and molecular makeup.

In this episode, we’ll explore how precision oncology is transforming the landscape of cancer care and improving outcomes at leading hospitals like St. Jude Children’s Research Hospital. We’ll discuss the latest precision diagnostic technologies enabling doctors to analyze a tumor’s molecular profile and match targeted therapies to save lives.

Join us as we investigate the promise of precision oncology to make treatment more effective and more equitable. Guests include:

  • Rick Shadyac, President and CEO at ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital, a Cambridge Associates client
  • Matt Gevaert, Co-Founder and Board Member at Kiyatec
  • Jason Robart, Co-Founder & Managing Partner at Seae Ventures
  • Jeff Blazek, previous Partner and Head of the Northeast & Midwest Endowment & Foundation Practice at Cambridge Associates, who works with ALSAC/St. Jude as one of his clients, in partnership with Anurag Pandit, CIO of ALSAC/SJCRH, and the Investment Department

Listen below or wherever you get your podcasts.

Apple Podcasts icon  Spotify icon

Amazon Music icon  RSS Feed

Read the transcript


Explore more episodes

Listen now

About

Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company. Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.

Enjoying the podcast? Subscribe, rate, and review Unseen Upside: Investments Beyond Their Returns on Apple Podcasts and Spotify.

Have an idea for an episode or interested in being a guest? Email unseenupside@cambridgeassociates.com to get involved.

Last Updated:

This website is directed and intended to be accessed by persons who satisfy any of the following criteria:

  1. A professional client or an eligible counterparty*
  2. A financial advisor or financial intermediary acting on behalf of a professional client or eligible counterparty*
  3. An employee or prospective employee

If you satisfy any of these criteria, please click confirm to proceed:

Please check this box to remember my choice

*As defined in the Markets in Financial Instruments Directive (Directive 2014/65/EC) as amended or updated (MiFID)

This website is directed and intended to be accessed by persons who satisfy any of the following criteria:

  1. A regulated financial entity*
  2. An institutional investor, investment professional and other entities or individuals who are qualified to operate in financial markets involving regulated financial activity as defined by its local country regulator
  3. An employee or prospective employee

If you satisfy any of these criteria, please click confirm to proceed:

Please check this box to remember my choice

*An entity regulated by its local country regulator which may include banks, collective investment schemes, endowments, foundations, investment managers, insurance companies, pension funds and intermediaries

The information contained herein is not suitable for retail investors.

Please contact us if you have any questions: ContactCA@cambridgeassociates.com

If you clicked decline in error, please click here